The FDA has finalized clinical guidance for developers of psychedelic drugs and scheduled a public hearing for September to explore potential therapeutic applications.
In a collaborative effort to accelerate treatment development, HHS and the Department of Veterans Affairs are partnering to advance research on rapid-acting psychedelic therapies for veterans suffering from severe mental health conditions.
A randomized trial published in Schizophrenia Bulletin found that individuals with schizophrenia and bipolar I disorder experienced improvements in clinical symptoms and cognitive function after four months on a ketogenic diet.
Research published in JAMA Otolaryngology-Head & Neck Surgery via systematic review and meta-analysis consistently linked the loss of smell with an elevated risk of depressive symptoms.
According to a cohort study in JAMA Network Open, continuing selective serotonin reuptake inhibitors during pregnancy was not associated with congenital anomalies or infant ICU admissions, though it was linked to delayed neonatal adaptation.
A quasi-experimental analysis in JAMA Psychiatry revealed that mass shootings were associated with a temporary nationwide increase in fatal motor vehicle crashes the following day.
Generative artificial intelligence holds promise for clinical psychopharmacology but should function only as a heavily supervised assistant managing lower-risk tasks, according to recommendations in the Journal of Clinical Psychiatry.
Researchers identified a correlation between excessive phone use in parents and insecure attachment styles in children, as reported in Frontiers in Psychology.
Meta, the parent company of Facebook and Instagram, has appealed a landmark jury verdict that held the platforms responsible for contributing to social media addiction in young users, according to AP.
After missing a self-imposed May deadline for deciding whether to ban electric shock devices, the FDA announced it will make a decision by November.
ADHD stimulant misuse dropped from 7.8% in 2022 to 3.7% in 2023, researchers noted in the Journal of Clinical Psychopharmacology, attributing the decline partially to an ongoing shortage of immediate-release medications.
A federal appeals court reinstated hundreds of lawsuits against Kenvue, the maker of acetaminophen (Tylenol), alleging that the painkiller used during pregnancy can cause autism or ADHD in offspring, Reuters via AOL reports.
A 32-year-old woman’s account of navigating an involuntary mental health hold highlights the critical shortage of psychiatric hospital beds across the U.S., KFF Health News reports.
Data from a cohort study published in JAMA Psychiatry showed that hospitalization for an infection was associated with a higher rate of psychiatric and neurological diagnoses over the subsequent two years.
The FDA granted 510(k) clearance to Universal Brain for its device that measures brain function using EEG and event-related potentials.
